Planet Labs (NYSE:PL) shares jumped nearly 12% to about $25 after the company announced a new multi-year, nine-figure agreement with the Swedish Armed Forces to provide satellites, space-based data, and awareness solutions to support Sweden’s military and security operations.
Under the agreement, Sweden will own a suite of Planet satellites and will have access to the company’s high-resolution data and intelligence products.
Moderna Inc (NASDAQ:MRNA, XETRA:0QF) said it expects 2025 revenue of approximately $1.9 billion, about $100 million above the midpoint of its previously communicated guidance of $1.6 to $2 billion.
The company also raised its 2025 GAAP operating expense outlook by $200 million to a range of $5 to $5.2 billion and projects a year-end cash balance of approximately $8.1 billion, including a $0.6 billion drawdown from a recently announced $1.5 billion term loan facility.
Shares of banks and credit card companies moved lower after US president Donald Trump proposed capping interest rates on cards to 10% for a year starting January 20, rekindling an idea initially put forward during his 2024 presidential campaign.
The average interest rate for credit cards in the US is reportedly about 20%.
NextSource Materials Inc. (TSX:NEXT, OTCQB:NSRCF) announced that it has finalized multiple term sheets with strategic investors to fund Phase 1 of its proposed Battery Anode Facility (BAF) in the Industrial City of Abu Dhabi, United Arab Emirates.
The company said the term sheets mark progress in its strategic financing process and support its path toward a final investment decision.
Shares in Futura Medical PLC (AIM:FUM, OTC:FAMDF) rose 11% to 1.45p on Monday after the company unveiled positive early-stage trial results for a new gel aimed at treating sexual dysfunction in women, a potential first in the over-the-counter market.
The AIM-listed group, best known for its erectile dysfunction product Eroxon, said its WSD4000 gel had shown “highly statistically significant” improvements in sexual function during a small feasibility study.